Position in REGN
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$157,880,328
+$6,227,322 QoQ
Shares Held
253,200
+29.0% QoQ
Ownership
0.246%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
#56
of 1,327 holders
Holding Since
Mar 2020
19 quarters on record
Voting authority
Sole 70%
Shared 0%
None 30%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026LSV ASSET MANAGEMENT holds $1,914,392,782 across 14 Biotechnology names. REGN ranks #4 (8.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
2,275,145 | $548,241,690 | |
| 2 | INCY |
Incyte Corp
|
4,123,759 | $467,469,320 | |
| 3 | EXEL |
Exelixis, Inc.
|
8,146,478 | $443,249,867 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
253,200 | $157,880,328 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
1,410,257 | $110,380,815 | |
| 6 | HRMY |
Harmony Biosciences Holdings, Inc.
|
2,061,242 | $75,049,821 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
881,700 | $50,450,874 | |
| 8 | RIGL |
Rigel Pharmaceuticals Inc
|
721,666 | $28,231,573 |
All Filings in REGN
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $157,880,328 | 253,200 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $151,653,006 | 196,279 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $128,527,161 | 166,514 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $31,262,212 | 55,600 | Shares | Sole | 2025-11-06 | |
| 2025-03-31 | $5,073 | 8 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $2,849 | 4 | Shares | Sole | 2025-02-13 | |
| 2023-03-31 | $40,590,498 | 49,400 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $37,589,629 | 52,100 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $37,061,206 | 53,800 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $33,930,862 | 57,400 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $133,908,066 | 191,730 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $126,466,300 | 200,257 | Shares | Sole | 2022-01-28 | |
| 2021-09-30 | $127,007,311 | 209,867 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $132,031,594 | 236,387 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $119,208,096 | 251,951 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $127,387,411 | 263,682 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $167,157,025 | 298,612 | Shares | Sole | 2020-10-23 | |
| 2020-06-30 | $200,588,291 | 321,636 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $188,059,034 | 385,138 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||